Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy.
CONCLUSIONS: The presence of immune-mediated adverse reactions is associated with a better response to immunotherapy. The association with a favorable response is even stronger in patients with radiologic manifestations of the immune-mediated adverse reactions. se criteria, immune-mediated adverse reactions, medical oncology (MeSH term).
PMID: 31405549 [PubMed - as supplied by publisher]
Source: Radiologia - Category: Radiology Authors: Ezponda Casajús A, Calvo Imirizaldu M, de Torres Tajes JP, García-Baizán A, Castañón Álvarez E, Cano Rafart D, Vivas Pérez I, Bastarrika Alemañ G Tags: Radiologia Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Melanoma | Myocarditis | Radiology | Skin Cancer | Thyroiditis